Literature DB >> 15344199

Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002.

Kyungwon Lee1, Young Ah Kim, Yeon Joon Park, Hye Soo Lee, Moon Yeun Kim, Eui Chong Kim, Dongeun Yong, Yunsop Chong.   

Abstract

Continued antimicrobial resistance surveillance can provide valuable information for the empirical selection of antimicrobial agents for patient treatment, and for resistance control. In this 6th annual study for 2002, the susceptibility data at 39 Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) hospitals were analyzed. Resistance rates of S. aureus were 67% to oxacillin, and 58% to clindamycin. The ampicillin and vancomycin resistance rates of E. faecium were 89% and 16%, respectively. To penicillin, 71% of S. pneumoniae were nonsusceptible. Resistance rates of E. coli were 11% to cefotaxime, 8% to cefoxitin, and 34% to fluoroquinolone, and those of K. pneumoniae were 22% to ceftazidime, and 16% to cefoxitin. Lowest resistance rates to cephalosporins shown by E. cloacae and S. marcescens were to cefepime, 7% and 17%, respectively. This is the first KONSAR surveillance, which detected imipenem-resistant E. coli and K. pneumoniae. To imipenem, 22% of P. aeruginosa and 9% of Acinetobacter spp. were resistant. Trends of resistances showed a slight reduction in MRSA and in penicillin- nonsusceptible S. pneumoniae, but an increase in ampicillin-resistant E. faecium. Ampicillin-resistant E. coli and H. influenzae remained prevalent. Compared to the previous study, amikacin- and fluoroquinolone- resistant Acinetobacter spp. increased to 60% and 62%, respectively. Ceftazidime- resistant K. pneumoniae decreased slightly, and imipenem- resistant P. aeruginosa and Acinetobacter spp., and vancomycin-resistant E. faecium increased. In conclusion, vancomycin-resistant E. faecium, cefoxitin-resistant E. coli and K. pneumoniae, and imipenem-resistant P. aeruginosa and Acinetobacter spp. increased gradually, and imipenem- resistant E. coli and K. pneumoniae appeared for the first time. Continued surveillance is required to prevent further spread of these serious resistances.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344199     DOI: 10.3349/ymj.2004.45.4.598

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  14 in total

1.  High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea.

Authors:  Won Sup Oh; Kwan Soo Ko; Jae-Hoon Song; Mi Young Lee; Sulhee Park; Kyong Ran Peck; Nam Yong Lee; Choon-Kwan Kim; Hyuck Lee; Shin-Woo Kim; Hyun-Ha Chang; Yeon-Sook Kim; Sook-In Jung; Jun Seong Son; Joon-Sup Yeom; Hyun Kyun Ki; Gun-Jo Woo
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.

Authors:  Yanling Xu; Bing Gu; Mao Huang; Haiyan Liu; Ting Xu; Wenying Xia; Tong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.

Authors:  Veronika L Tchesnokova; Linda L Ottley; Kyoko Sakamoto; Joshua Fierer; Evgeni Sokurenko; Michael A Liss
Journal:  Urology       Date:  2015-08-20       Impact factor: 2.649

4.  Rifaximin for the treatment of acute infectious diarrhea.

Authors:  Kyoung Sup Hong; Joo Sung Kim
Journal:  Therap Adv Gastroenterol       Date:  2011-07       Impact factor: 4.409

Review 5.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

6.  Efficacy of rifaximin compared with ciprofloxacin for the treatment of acute infectious diarrhea: a randomized controlled multicenter study.

Authors:  Kyoung Sup Hong; You Sun Kim; Dong Soo Han; Chang Hwan Choi; Byung-Ik Jang; Young-Sook Park; Kang-Moon Lee; Soo Teik Lee; Hyun-Soo Kim; Joo Sung Kim
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

7.  Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.

Authors:  Michael A Liss; Alexandra Chang; Rosanne Santos; Amy Nakama-Peeples; Ellena M Peterson; Kathryn Osann; John Billimek; Richard J Szabo; Atreya Dash
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

8.  Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

Authors:  Jun Yong Choi; Chang Oh Kim; Yoon Seon Park; Hee Jung Yoon; So Youn Shin; Young Keun Kim; Myung Soo Kim; Yeon-A Kim; Young Goo Song; Dongeun Yong; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

9.  Metallo-beta-lactamase-producing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type.

Authors:  Kyungwon Lee; Ae Ja Park; Moon Yeun Kim; Hee Joo Lee; Ji-Hyun Cho; Jung Oak Kang; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

10.  Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions.

Authors:  Hee-Jung Chung; Hong-Seon Jeon; Heungsup Sung; Mi-Na Kim; Soo-Jong Hong
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.